It should be noted that two patients in our cohort had somatic mutations in MYO3A and MYO3B (patients 17 and 33, respectively), further indicating a role for these genes in sarcoma (Supplementary Figure 2 and Supplementary Data 3). This evidence concerns the gene MYO3A and sarcoma.